Pure Global
NCT06106230

Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint

MTI University·ClinicalTrials.gov·combination productNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Plaque Psoriasis
Drug/Device/Intervention
Bee venom phonophoresis
Study type
Interventional
Intervention type
combination product
Sponsor & location
Primary sponsor
MTI University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Apr 25, 2024
Enrollment
100 participants
Primary outcome

Neutrophils / Lymphocyte Ratio (Neutrophil-to-Lymphocyte Ratio),C-reactive protein (CRP),(ESR) erythrocyte sedimentation rate

Summary

Chronic plaque psoriasis, or psoriasis vulgaris, is a chronic inflammatory skin disease
 characterized by well demarcated, erythematous, scaly plaques on the extensor surfaces of the
 body and scalp. The lesions may occasionally itch or sting, and may bleed when injured.
 Dystrophic nail changes or nail pitting are found in more than one third of people with
 chronic plaque psoriasis, and psoriatic arthropathy occurs in 1% to more than 10%. The
 condition waxes and wanes, with wide variations in course and severity among individuals.

ICD-10 classifications
PsoriasisLarge plaque parapsoriasisOther psoriasisSmall plaque parapsoriasisArthropathic psoriasis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06106230
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06106230 through Pure Global AI's free database. This phase not specified trial is sponsored by MTI University and is currently Not yet recruiting. The study focuses on Plaque Psoriasis. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.